ePrescribing Market worth $253.79 million by 2030, growing at a CAGR of 8.05% - Exclusive Report by 360iResearch

The "ePrescribing Market by Offrings (Services, Solution), Delivery Mode (On premise, Web & Cloud based), End User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global ePrescribing Market to grow from USD 147.53 million in 2023 to USD 253.79 million by 2030, at a CAGR of 8.05%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/eprescribing?utm_source=openpr&utm_medium=referral&utm_campaign=sample

E-prescribing refers to the process of healthcare professionals generating and sending prescription orders directly to a pharmacy or healthcare facility through digital platforms. This sophisticated methodology transcends traditional paper-based prescriptions, significantly streamlining the prescribing process. It encompasses the utilization of electronic devices, such as computers and smartphones, allowing for increased accuracy, enhanced patient safety, and improved efficiency in prescription fulfillment. E-prescribing systems are integrated with patient medical records, thereby enabling prescribers to access comprehensive patient medication histories, contraindications, and allergies, ensuring optimal medication management and decision-making. Government initiatives and incentives for adopting healthcare IT solutions are increasing the applications of e-prescribing. Demand for reduced prescribing errors and improved healthcare delivery further boosted the demand for the market. However, significant investment required for setup, maintenance, and training may impede market growth. Nevertheless, integration with Electronic Health Record (EHR) systems and advanced analytics and decision support tools for personalized medication management may provide an opportunistic view for market growth.

In the Americas, ePrescribing has experienced rapid adoption due to supportive regulatory frameworks and initiatives aimed at improving healthcare efficiency and patient safety. In the U.S., the Health Information Technology for Economic & Clinical Health Act and the Medicare Prescription Drug Improvement and Modernization Act have significantly propelled the use of ePrescribing systems. Canada and Brazil are also observing substantial growth in ePrescribing adoption, driven by government policies promoting digital health infrastructure and initiatives to curb prescription errors. The region is characterized by a competitive market environment with numerous providers offering a variety of solutions that integrate with electronic health record systems. The EMEA region presents a diverse picture of ePrescribing adoption, with Europe leading in implementation. The European Union's directives aimed at the adoption of cross-border eHealth services, including ePrescriptions, have encouraged member states to accelerate digital health initiatives. The Asia Pacific region is witnessing fast-paced growth in the ePrescribing market, spurred by its large population, growing middle class, and increasing emphasis on healthcare IT initiatives. Countries including Australia, Singapore, and Japan are leading in ePrescribing adoption, supported by strong digital health infrastructures and government incentives. India and China are emerging markets with significant potential, driven by initiatives to improve healthcare access and the digitization of healthcare systems.

Market Segmentation & Coverage:

This research report categorizes the ePrescribing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Offrings, market is studied across Services and Solution. The Services is further studied across Implementation and Network. The Solution is further studied across Integrated, and Standalone. The Solution is projected to witness significant market share during forecast period.

Based on Delivery Mode, market is studied across On premise and Web & Cloud based. The On premise is projected to witness significant market share during forecast period.

Based on End User, market is studied across Hospitals, Pharmacies, and Physician Offices. The Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 41.12% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/eprescribing?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the ePrescribing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the ePrescribing Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the ePrescribing Market, highlighting leading vendors and their innovative profiles. These include 75health, Allscripts Healthcare Solutions Inc., athenahealth, Inc., Dosespot by PRN Software, LLC, DrChrono, DrFirst Inc., eazyScripts Technology, LLC, eClinicalWorks, eMDs, Inc. by CompuGroup Medical, Epocrates Inc., Healthie Inc., iCoreConnect, Intelligent Medical Software, Kareo, Inc. by Tebra Technologies, Inc., MDToolbox, MedicalMine Inc., Networking Technology, Inc., NextGen Healthcare, Inc., Optum, Inc., Oracle Corporation, Pabau, Provet Cloud, Qualifacts Systems, LLC, Surescripts, LLC, and Wolters Kluwer N.V..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. ePrescribing Market, by Offrings
7. ePrescribing Market, by Delivery Mode
8. ePrescribing Market, by End User
9. Americas ePrescribing Market
10. Asia-Pacific ePrescribing Market
11. Europe, Middle East & Africa ePrescribing Market
12. Competitive Landscape
13. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the ePrescribing Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the ePrescribing Market?
3. What is the competitive strategic window for opportunities in the ePrescribing Market?
4. What are the technology trends and regulatory frameworks in the ePrescribing Market?
5. What is the market share of the leading vendors in the ePrescribing Market?
6. What modes and strategic moves are considered suitable for entering the ePrescribing Market?

Read More @ https://www.360iresearch.com/library/intelligence/eprescribing?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.